[go: up one dir, main page]

Gallivan et al., 1997 - Google Patents

Site-specific incorporation of biotinylated amino acids to identify surface-exposed residues in integral membrane proteins

Gallivan et al., 1997

View PDF
Document ID
11797708116360588027
Author
Gallivan J
Lester H
Dougherty D
Publication year
Publication venue
Chemistry & biology

External Links

Snippet

Background: A key structural issue for all integral membrane proteins is the exposure of individual residues to the intracellular or extracellular media. This issue involves the basic transmembrane topology as well as more subtle variations in surface accessibility. Direct …
Continue reading at www.cell.com (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Similar Documents

Publication Publication Date Title
Gallivan et al. Site-specific incorporation of biotinylated amino acids to identify surface-exposed residues in integral membrane proteins
US5368712A (en) Biologically mimetic synthetic ion channel transducers
Yip et al. A propofol binding site on mammalian GABAA receptors identified by photolabeling
Zheng et al. Conformations of IgE bound to its receptor Fc. epsilon. RI and in solution
Scapin et al. Multifaceted roles of crystallography in modern drug discovery
JP2005501220A (en) Identification of target-specific folding sites in peptides and proteins
Schiedel et al. Prediction and targeting of interaction interfaces in G-protein coupled receptor oligomers
Vogel et al. Structural fluctuations between two conformational states of a transmembrane helical peptide are related to its channel‐forming properties in planar lipid membranes
Yan et al. The spider toxin ω-Aga IIIA defines a high affinity site on neuronal high voltage-activated calcium channels
Hruby et al. New paradigms and tools in drug design for pain and addiction
Fletcher-Taylor et al. Distinguishing potassium channel resting state conformations in live cells with environment-sensitive fluorescence
Woppmann et al. Calcium channel subtypes in rat brain: biochemical characterization of the high-affinity receptors for ω-conopeptides SNX-230 (synthetic MVIIC), SNX-183 (SVIB), and SNX-111 (MVIIA)
Mager et al. Bridging the gap between structural bioinformatics and receptor research: the membrane-embedded, ligand-gated, P2X glycoprotein receptor
Hayward et al. Strategies for converting turn-motif and cyclic peptides to small molecules for targeting protein–protein interactions
JP2009514529A (en) TRPM8 and calmodulin polypeptide complexes and their uses
Darman et al. Constraints on voltage sensor movement in the shaker K+ channel
US20040180401A1 (en) Methods of determining precise HERG interactions and designing compounds based on said interactions
Engström et al. Assessing activation of the human neuropeptide FF2 receptor with a non-radioactive GTP binding assay
Guerrini et al. Nonpeptide/peptide chimeric ligands for the nociceptin/orphanin FQ receptor: design, synthesis and in vitro pharmacological activity
Watson et al. Design, synthesis and evaluation of E2‐25K derived stapled peptides
JP2003528599A (en) G protein-coupled receptor
Beinborn et al. Small synthetic ligands of the cholecystokinin-B/gastrin receptor can mimic the function of endogenous peptide hormones
Daminato Nmr-Based Investigation of the Neurotransmitter/Sodium Symporter Homologue LeuT
Schuster Peptide Based Biosensors And Mass Spectrometric Methods To Measure The Activation Of Tyrosine Kinases
Lithgow New chemical approaches for the development of targeted protein degradation